Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Enrique Alvarez

Showing results (1-10 of 247) with videos related to

Pageof 25
Sort By:
Neurologic Clinics|November 18, 2023
Advances in Multiple Sclerosis Neurotherapeutics, Neuroprotection, and Risk Mitigation StrategiesAhmad Abdelrahman, Enrique Alvarez
Multiple Sclerosis Journal - Experimental, Translational and Clinical|June 2, 2026
Absence of significant hematologic abnormalities in breastfed infants of mothers with multiple sclerosis treated with anti-CD20 therapiesAnna Shah, Enrique Alvarez
Neurology. Clinical Practice|September 6, 2021
COVID-19 Vaccination in Patients With Multiple Sclerosis on Disease-Modifying TherapyAndrew Wolf, Enrique Alvarez
Brain Sciences|November 27, 2024
Engineering and Technological Advancements in Repetitive Transcranial Magnetic Stimulation (rTMS): A Five-Year ReviewAbigail Tubbs, Enrique Alvarez Vazquez
Biomedicines|March 17, 2019
Monoclonal Antibodies in Multiple Sclerosis: Present and FutureNatalia V Voge, Enrique Alvarez
Neurologic Clinics|March 29, 2011
The immunopathophysiology of multiple sclerosisGregory F Wu, Enrique Alvarez
Journal of Biomedical Informatics|August 10, 2025
Digital twins in increasing diversity in clinical trials: A systematic reviewAbigail Tubbs, Enrique Alvarez Vazquez
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 23, 2018
We need to conduct clinical trials of disease-modifying therapy in pregnancy to optimize care of women with MS - YesEnrique Alvarez, Ellen M Mowry
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 3, 2026
Do MRI-negative relapses really exist? - NoAndrew B Wolf, Enrique Alvarez
Neurology|February 26, 2015
Severe anemia in a patient with multiple sclerosis treated with natalizumabJulie B Seibert, Enrique Alvarez
Pageof 25

Showing results (1-10 of 247) with videos related to

Sort By:
Pageof 25
Neurologic Clinics|November 18, 2023
Advances in Multiple Sclerosis Neurotherapeutics, Neuroprotection, and Risk Mitigation StrategiesAhmad Abdelrahman, Enrique Alvarez
Multiple Sclerosis Journal - Experimental, Translational and Clinical|June 2, 2026
Absence of significant hematologic abnormalities in breastfed infants of mothers with multiple sclerosis treated with anti-CD20 therapiesAnna Shah, Enrique Alvarez
Neurology. Clinical Practice|September 6, 2021
COVID-19 Vaccination in Patients With Multiple Sclerosis on Disease-Modifying TherapyAndrew Wolf, Enrique Alvarez
Brain Sciences|November 27, 2024
Engineering and Technological Advancements in Repetitive Transcranial Magnetic Stimulation (rTMS): A Five-Year ReviewAbigail Tubbs, Enrique Alvarez Vazquez
Biomedicines|March 17, 2019
Monoclonal Antibodies in Multiple Sclerosis: Present and FutureNatalia V Voge, Enrique Alvarez
Neurologic Clinics|March 29, 2011
The immunopathophysiology of multiple sclerosisGregory F Wu, Enrique Alvarez
Journal of Biomedical Informatics|August 10, 2025
Digital twins in increasing diversity in clinical trials: A systematic reviewAbigail Tubbs, Enrique Alvarez Vazquez
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 23, 2018
We need to conduct clinical trials of disease-modifying therapy in pregnancy to optimize care of women with MS - YesEnrique Alvarez, Ellen M Mowry
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 3, 2026
Do MRI-negative relapses really exist? - NoAndrew B Wolf, Enrique Alvarez
Neurology|February 26, 2015
Severe anemia in a patient with multiple sclerosis treated with natalizumabJulie B Seibert, Enrique Alvarez
Pageof 25